The results of our work are potentially relevant as a precision-medicine foundation for other coagulation disorders as well, such as hemophilia, von Willebrand disease, factor V Leiden, pulmonary embolism, deep vein thrombosis, stroke, and sickle cell disease. This evidence concerns the gene F5 and blood coagulation disease.